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Purpose:This study was conducted to identify factors involved in lymph node metastasis
(LNM) and evaluate their role in predicting LNM in clinically lymph node negative (clinical
stage I–III) intrahepatic cholangiocarcinoma (ICC). Materials and Methods:We selected
320 patients whowere diagnosedwith ICCwith no apparent clinical LNM (T1–3N0M0). Age,
gender, tumor boundary, histological differentiation, tumor size, and carbohydrate antigen
19-9 value were the studied factors. Univariate and multivariate logistic analysis were con-
ducted. Receiver operating characteristics curve analysis was used to test the predicting
value of each factor and a test which combined the associated factors was used to predict
LNM. Results: LNMwas observed in 76 cases (76/320, 23.8%). Univariate andmultivariate
analysis showed that histological differentiation as well as tumor boundary and tumor size
signiﬁcantly correlated with LNM. The sensitivity and negative predictive value for LNM
for the three factors when combined was 96.1 and 95% respectively. This means that
5% of the patients who did not have the risk factors mentioned above developed LNM.
Conclusion: This model used the combination of three factors (low-graded histological
differentiation, distinct tumor boundary, small tumor size) and they proved to be useful in
predicting LNM in ICC with clinically lymph node negative cases. In patients with these
criteria, lymph node dissection or lymph node irradiation may be omitted and such cases
may also be good candidates for stereotactic body radiotherapy (SBRT).
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INTRODUCTION
Intrahepatic cholangiocarcinoma (ICC) is a primary malignant
tumor arising peripherally to the secondary bifurcation of the left
or right hepatic duct. ICC is a relatively rare liver tumorwhen com-
pared to hepatocellular carcinoma (HCC). ICC accounts for about
5–30% of primary liver tumors (Kaczynski et al., 1998; Yamamoto
et al., 1998; Shaib and El-Serag, 2004). Surgical resection improves
long-term survival in patients with ICC but the prognosis after
aggressive resection remains unsatisfactory (Ohtsuka et al., 2002).
Overall resectability rates were 54.6% in a study from Japan (Ikai
et al., 2004) and 62% in a study from the United States (Weber
et al., 2001) with the 1 and 3 year cumulative survival rates after
resection being 49.4–76.6 and 17.3–52.7%, respectively (Fu et al.,
2004; Shinohara et al., 2008; Choi et al., 2009; Lang et al., 2009).
However, othermethods such as radiotherapy have been examined
in many retrospective series with promising results with respect to
local control and survival beneﬁt (Zeng et al., 2006; Chen et al.,
2010; Jiang et al., 2010; Saxena et al., 2010a). Adjuvant and deﬁn-
itive radiotherapy may play an important role in the treatment of
ICC in the future.
Lymph node metastasis (LNM) has been reported to be a sig-
niﬁcant prognostic factor in ICC (Hanazaki et al., 2002; Fu et al.,
2004; Nakagawa et al., 2005; Choi et al., 2009; Guglielmi et al.,
2009; Saxena et al., 2010b). It is also important to decide whether
a patient with ICC should be considered for irradiation of the
regional lymph nodes. If the absence of nodal metastasis is accu-
rately detected, there would be no need for an extended irradiation
ﬁeld and thus the role of radiation therapy will become more sig-
niﬁcant. Therefore, identiﬁcation of clinicopathologic factors that
predict the status of lymph nodes in ICC could have potential clin-
ical beneﬁts. Till date, there are no accurate pre-operative factors
that can predict LN metastasis. However, by using a combina-
tion of pre-operative factors, it might be possible to accurately
categorize a subset of patients with no LNM.
In this study, 320 surgical cases with clinically negative lymph
node (T1–3N0M0) ICC were analyzed and the factors associated
with LNM were studied. The objectives of this study were to deter-
mine whether we could predict normal or metastatic lymph nodes
using our approach and therefore avoiding unnecessary regional
lymph node irradiation in selected patients with ICC.
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MATERIALS AND METHODS
PATIENTS AND DIAGNOSIS
From January 2000 to January 2010, 370 patients with histolog-
ically proven ICC underwent hepatectomy at the Liver Cancer
Institute, Zhongshan hospital, Fudan University. In this group,
320 patients had no metastasis to regional lymph nodes as per
pre-operative images (CT/MRI). This study was approved by the
ethical review board of Zhongshan Hospital, Fudan University.
Intrahepatic cholangiocarcinomawas conﬁrmedbyhistopatho-
logical examination and the medical history and examination.
HCC and metastasis from gastrointestinal cancers were ruled out
by immunohistochemical staining for Hepa, CK7, CK19, CK20,
alpha fetoprotein (AFP), MUC5AC, and MUC6. Positive staining
for MUC5AC and CK7 together with negative staining for MUC6
and CK20 was suggestive of ICC. On the other hand, positive
staining for MUC6 and CK20 combined with negative staining
for MUC5AC and CK7 was suggestive of liver metastasis from
colorectal cancer. The serum tumor markers such as carcinoem-
bryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), and
AFP were also used as diagnostic tools to exclude HCC or mixed
ICC/HCC.
Radiological images such as enhanced CT or MRI (or both)
were used to assess the state of the tumor in the liver and to deter-
mine the tumorboundary, tumor size, and thepresence of multiple
nodules. We found that the boundary of ICC can be divided into
two different forms based on radiological images: 1. During the
arterial phase, ICC can have a distinct boundary, which appears as
a regular border with a thin, ring-like iso-attenuated or enhanced
structure relative to the liver (Figure 1A); 2. The second form
has an obscure boundary that is characterized by an ill-deﬁned
border (Figure 1B). Assessment of tumor size was based on the
largest dimension of the tumor. Multiple nodules were deﬁned
as the presence of two or more nodules, including intrahepatic
metastases and satellite lesions. Nodal size is the current standard
criteria for the deﬁning LNM on imaging studies and lymph nodes
measuring 1 cm or more in minimum diameter were regarded as
metastatic. The following pre-operative demographics and clinical
information were retrospectively obtained from patients’ medical
records: age, gender, andCA19-9. Tumor stagewas deﬁned accord-
ing to the American Joint Committee on Cancer (AJCC) seventh
edition staging for ICC (Nathan and Pawlik, 2010).
The locations of LNM were classiﬁed as reported by the
Liver Cancer Study Group of Japan (1997). The hilum, cystic
FIGURE 1 | (A) CT scan showing an intrahepatic cholangiocarcinoma that
appears as a low-density area and has a regular, distinct boundary. (B) CT
scan showing an intrahepatic cholangiocarcinoma with an obscure
boundary.
duct, pericholedochal nodes, periportal nodes, and proper hepatic
nodes around and in the hepatoduodenal ligament were grouped
together as the hepatic hilum nodes (N1 group). The nodes in the
pancreatic head and around the common hepatic artery and celiac
trunk were deﬁned as the N2 group. The N3 group was deﬁned
as the nodes around the para-aorta, major omenta, paracolic, and
paramesenteric areas.
STATISTICAL ANALYSIS
In order to assess the factors which predict the probability of
metastasis to lymph node,we ﬁrst used univariate analysis (logistic
regression model) to assess the following: age (less than 65 years,
65 years or older), gender, tumor boundary (distinct, obscure),
the grade of differentiation (low: well to moderately; high: poorly
to undifferentiated), tumor size (5 cm or less, more than 5 cm),
multiple nodules, and CA19-9 (normal range: 37 ng/ml or less;
abnormal value: more than 37 ng/ml). All variables which were
signiﬁcant (P-value less than 0.05) in the univariate analysis were
entered in the multivariate analysis in order to discriminate the
signiﬁcant risk factors for LN metastases.
Receiver operating characteristic (ROC) curves were used to
determine the predictive value of the parameters. Sensitivity, speci-
ﬁcity, positive predictive value (PPV), negative predictive value
(NPV), and the accuracy were obtained for each of the testing
method based on the binomial distribution.
All reported P-values are two sided. In both of the univari-
ate and multivariate analyses, the relative risks (RRs) and their
respective 95% conﬁdence intervals (CIs) from the logistic regres-
sion model were reported. All statistical analyses were performed
using SPSS, version 15.0 forWindows (Statistical Product and Ser-
vices Solutions, SPSS Inc, Chicago, IL, USA). A value of P < 0.05
was considered statistically signiﬁcant.
RESULTS
DEMOGRAPHIC DATA
There were 136 females and 184 males in this study. The median
age was 56.9± 11.33 years (range 18–89 years). The tumor diam-
eter ranged from 0.8 to 15 cm, with a median diameter of
6.1± 2.89 cm. 236 patients (73.8%) had a low-grade lesions and
84 patients (26.2%) had a high-grade lesions. The other patients’
characteristics including tumor boundary, number of nodes, and
CA19-9 are provided in Table 1.
Two hundred (62.5%) patients had stage I cancer, 82 (25.6%)
had stage II cancer and 38 (11.9%) had stage III and staging was
carried out according to the seventh edition of the UICC-TNM
staging system for ICC.
Among all the 320 patients, 76 (23.8%) were conﬁrmed to have
LNM by pathological examination. The most common site of
LNM was the hepatic hilum (N1, n = 54, 67.8%) while other sites
were the peripancreatic head (N2, n = 17, 25.9%) as well as the
para-aortic area and the major omenta (N3, n = 5, 6.3%).
ANALYSIS OF THE FACTORS ASSOCIATED WITH LNM
In order to develop a model for predicting LNM, we ﬁrst con-
ducted a univariate analysis to test the predictive value of the
following potential categorical predictors: gender, age, tumor
boundary, tumor size, multiple nodules, histological differen-
tiation, and CA19-9. As shown in the Table 2, we found
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Table 1 | Patient characteristics.
Characteristic Number (%)
Gender
Female 136 (42.5%)
Male 184 (57.5%)
Age (years)
≤65 240 (75.0%)
>65 80 (25.0%)
Tumor boundary
Distinct 155 (48.4%)
Obscure 165 (51.6%)
CA19-9 (U/L)
≤37 135 (42.2%)
>37 185 (57.8%)
Tumor size (cm)
≤5 147 (45.9%)
>5 173 (54.1%)
Multiple nodules
No 242 (75.6%)
Yes 78 (24.4%)
Pathological differentiation
Low (well to moderately differentiation) 236 (73.8%)
High (poorly to undifferentiated differentiation) 84 (26.3%)
Clinical staging
I 200 (62.5%)
II 82 (25.6%)
III 38 (11.9%)
Lymph node metastasis
No 244 (76.3%)
Yes 76 (23.8%)
CA19-9, carbohydrate antigen 19-9.
that LNM was associated with elevated CA19-9 (P = 0.017,
RR= 1.955), tumor boundary (P = 0.01, RR= 2.512), tumor
size (P = 0.005, RR= 2.202), and the histological differentiation
(P < 0.01, RR= 7.630).
All variables that were signiﬁcant in the univariate analy-
sis were selected and a multivariate analysis was conducted.
The variables that reached signiﬁcance in the multivariate
analysis were the tumor size (P = 0.006, RR= 2.371), tumor
boundary (P = 0.009, RR= 2.250) and histological differentiation
(P < 0.001, RR= 7.355; Table 3). However, CA19-9 was not an
independent factor for predicting LNM in multivariate analysis
(RR= 0.674, P = 0.105).
PREDICTION MODEL FOR LNM USING TUMOR BOUNDARY, TUMOR
SIZE, AND HISTOLOGICAL DIFFERENTIATION
Receiver operating characteristic curve analysis was performed for
these predictive factors. The area under the curve (AUC) and the
95% CI were used to assess the power of these factors in predict-
ing the LNM (Figure 2). ROC analysis showed that histological
differentiation was accurate in predicting LNM (AUC: 0.716; 95%
CI: 0.645–0.788; P < 0.001), followed by tumor boundary (AUC:
0.611; 95% CI: 0.539–0.682; P = 0.004) and tumor size (AUC:
0.594; 95% CI: 0.522–0.666; P = 0.013; Table 4).
Table 2 | Results of the univariate analysis of factors associated with
LNM.
Factor RR 95% CI P -value
Gender
Female 1
Male 0.671 0.400–1.126 0.131
Age (years)
≤65 1
>65 0.828 0.499–1.525 0.544
Tumor boundary
Distinct 1
Obscure 2.512 1.456–4.333 0.001
CA-199 (U/L)
≤37 1
>37 1.955 1.128–3.390 0.017
Tumor size (cm)
≤5 1
>5 2.202 1.277–3.798 0.005
Multiple nodules
No 1
Yes 1.368 0.767–2.439 0.289
Pathological differentiation
Low (well to moderately
differentiation)
1
High (poorly to undifferenti-
ated differentiation)
7.63 4.309–13.512 <0.001
RR, relative risk; CI, conﬁdence interval; CA19-9, carbohydrate antigen 19-9; LNM,
lymph node metastasis.
Table 3 | Results of the multivariate analysis of factors associated with
LNM.
Factor RR 95% CI P -value
Tumor boundary
Distinct 1
Obscure 2.25 1.224–4.137 0.009
CA-199 (U/L)
≤37 1
>37 1.674 0.898–3.118 0.105
Tumor size (cm)
≤5 1
>5 2.371 1.280–4.391 0.006
Pathological differentiation
Low (well to moderately
differentiation)
1
High (poorly to undifferenti-
ated differentiation)
7.355 4.053–13.348 <0.001
RR, relative risk; CI, conﬁdence interval; CA19-9, carbohydrate antigen 19-9; LNM,
lymph node metastasis.
The sensitivity/speciﬁcity, PPV/NPV, and the accuracy after the
combination of two or three signiﬁcant factors for LNM are sum-
marized in Table 5. Conspicuously, the sensitivity/speciﬁcity and
PPV/NPVby combining the three factors (tumorboundary, tumor
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FIGURE 2 | Receiver operating characteristic analysis: ROC analysis of
histological differentiation, tumor boundary, and tumor size.The AUC
of all parameters was less than 0.5, indicating that they were predictive of
LNM.
Table 4 | Area under the curve demonstrating the discriminatory
power of each factor for predicting LNM.
Factor AUC SE 95% CI P
Pathological differentiation 0.716 0.37 0.645–0.788 <0.001
Tumor boundary 0.611 0.36 0.539–0.682 0.004
Tumor size 0.594 0.37 0.522–0.666 0.013
AUC, area under the curve; CI, conﬁdence interval; LNM, lymph nodemetastasis;
SE, standard error.
size, and histological differentiation) for LNM were 96.1/23.0 and
28.0/95.0%, respectively. Furthermore, the accuracy was 40.3%.
This means that among the 59 patients (18.4%) who had none of
these three risk factors, only three patients had LNM. For these
speciﬁc patients, regional lymph node irradiation may be omitted
during radiotherapy.
Furthermore, we found that 73 patients (73/76, 90.1%) with
LN metastasis had at least one risk factor: 18 patients had one risk
factor, 34 patients had two risk factors, and 21 patients had three
risk factors. 56 patients (56/244, 23.0%) without LN metastasis
had no signiﬁcant risk factors. In the remaining 188 patients with-
out LN metastasis, 111 patients had one risk factor, 69 patients had
two risk factors and 8 patients had three risk factors.
DISCUSSION
Unlike HCC, ICC is commonly associated with LNM. This study,
which was conducted on a relative large number of patients and
showed that the incidence of LNM for those patients without pre-
operative node evaluation was 23.8% (76/320); LNM has been
reported to be associated with poor prognosis in patients with ICC
(Hanazaki et al., 2002; Fu et al., 2004; Zeng et al., 2006; Chen et al.,
2010; Jiang et al., 2010; Saxena et al., 2010a) plus it is also important
in deﬁning the target volume for the radiation oncologist.
Table 5 | Sensitivity, specificity, positive predictive value (PPV),
negative predictive value (NPV), and accuracy of factors significant on
multivariate analysis.
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
Accuracy
(%)
Tumor size combined
with tumor boundary
92.1 26.6 28.1 91.5 42.2
Tumor size combined
with pathological
differentiation
88.2 42.2 32.2 92.0 53.1
Pathological
differentiation
combined with
tumor boundary
84.2 45.5 32.5 90.2 54.6
Pathological
differentiation
combined with
tumor boundary and
Tumor size
96.1 23.0 28.0 95.0 40.3
Previous studies (Bluestein et al., 1994; Narayan et al., 1994;
Fuwa et al., 2007) have developed models based on clinical or
pathologic data so as to predict the risk of lymph node metastases
for other cancers such as lung cancer and prostate cancer. This
information is important so as to decide whether a cancer patient
should undergo a staging lymphadenectomy (including laparo-
scopic technique) or directly considered for irradiation of the
regional lymph nodes; however, limited data is available regarding
ICC and LNM prediction. Since radiotherapy may play an impor-
tant role in the treatment of ICC in the future, it is time to discuss
how to delineate the target volume in patients with ICC. Therefore,
the aim of this study was to try to determine whether we could
accurately predict nodal status preoperatively in ICC and avoid
unnecessary regional lymph node irradiation in selected patients.
This study indicates that we can avoid unnecessary lymph node
region irradiation in about 18.4% of patients with ICC who had
none of the tested clinicopathologic factors.
In this study, we tried to analyze the correlation between clin-
icopathologic factors and LNM. Univariate analysis test showed
that LNM was associated with histological differentiation, tumor
boundary, tumor size, and CA19-9 serum levels. Multivariate
logistic analysis revealed that only histological differentiation,
tumor boundary, and tumor size, demonstrated aggressive tumor
characteristics and were independent predictors for LNM. His-
tological differentiation and tumor size may be because of the
biological behavior of ICC. Poor differentiated or undifferenti-
ated tumors togetherwith large tumor size points toward increased
invasiveness. Even though few previous reports have described the
type of tumor boundary on imaging for ICC, it was found to be
a good predictor for microinvasion (Bi et al., 2010). In our study,
tumor boundary is also associated with LNM. In addition, histo-
logical differentiation was a superior predictor of LNM as shown
by a ROC-based approach.
Patients with elevated CA19-9 levels are more likely to develop
recurrent disease and survive for a shorter time than patients with
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normal CA19-9 levels; higher CA19-9 levels are associated with
more advanced TNM stages (Endo et al., 2008; Hatzaras et al.,
2010). However, in our study, the CA19-9 value was found to be
a signiﬁcant factor based on the univariate analysis but not based
on the multivariate analysis.
The overall accuracy for detecting metastatic lymph nodes
by pre-operative imaging has been reported to be 57–82.2%
(Hanazaki et al., 2002; Park et al., 2006; Kim et al., 2008). The most
common error in pre-operative imaging is underestimation of
the nodal involvement (Vilgrain, 2008). Therefore, combining the
factors listed above may help improve pre-operative evaluation of
LNMforpatientswith clinically negative lymphnode. Inour study,
with the combination two of the three factors (tumor bound-
ary, tumor size, and histological differentiation), the sensitivity
and NPV were 84.2–92.1 and 90.2–92.0%, respectively. Consider-
ing the clinical signiﬁcance of LN metastasis and its importance
for the delineation of target volume, the tests required to predict
LN metastasis should show high sensitivity and high NPV. The
sensitivity and NPV of the three combined pre-operative criteria
in our study reached 96.1 and 95%, respectively. This suggested
that if a patient with a small tumor size (less than 5 cm), dis-
tinct tumor boundary and low-grade differentiation, the chance
for LNM is very low (5%) and also indicates that regional lymph
node irradiation may be omitted in these speciﬁc cases.
Technological advances in radiation planning, breathing
motion reduction strategies, and image guidance have made it
possible for radiation to be delivered conformally to focal liver can-
cers while reducing the risk of toxicity. Stereotactic body radiation
therapy (SBRT), referring to an improved spatial distribution of
the administered dose and delivering the potent radiation in fewer
fractions, has also been used safely and efﬁciently for intrahepatic
tumors (Mendez Romero et al., 2006; Tse et al., 2008). This is a
highly attractive treatment option in a palliative situation where
overall treatment time is signiﬁcantly reduced. In our study, cases
where the histological differentiation is low-grade, the tumor
boundary is distinct, and the tumor size is less than 5 cm, the
probability of LNM is low and for these patients SBRT may be a
good choice.
The current study is limited because it is a small-scale retro-
spective hospital-based study at a single institution. Large-sized
multi-center studieswill be needed to conﬁrmour results.Another
important limitation of this study relates to the discrimination of
tumor boundary. The classiﬁcation of tumor boundary is highly
subjective and therefore the inclusion of this factor could affect the
accuracy of the prediction system. Consequently, a strict classiﬁca-
tion system is needed to deﬁne this parameter in the future. Finally,
this large series was conducted over a long period (2000–2009);
both diagnostic and therapeutic procedures for ICChave consider-
ably changed over these years. Thus, these developments probably
contributed to variance in the correlation between pre-operative
characteristics and LNM.
In conclusion, it has been demonstrated that cases with low-
grade differentiation, distinct tumor boundary and tumor size of
no more than 5 cm, the probability of LNM is very low (5%). The
tested combination of the three factors is useful for the predic-
tion of patients without LN metastasis and we could safely omit
regional lymph node irradiation in about a ﬁfth of patients with
ICC while these cases are also good candidates for SBRT.
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